These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Urinary calculi and infection]. Trinchieri A Urologia; 2014; 81(2):93-8. PubMed ID: 24874306 [TBL] [Abstract][Full Text] [Related]
3. The effect of oral acetohydroxamic acid on urinary saturation in stone-forming spinal cord patients. Burr RG; Nuseibeh I Br J Urol; 1983 Apr; 55(2):162-5. PubMed ID: 6839086 [TBL] [Abstract][Full Text] [Related]
4. Acetohydroxamate in struvite stones: in vivo study. Aroldi A; Graziani G; Castelnovo C; Colussi G; Surian M; Mandressi A; Mascheroni E; Pazardjiklian I; Pagano A; Ponticelli C Proc Eur Dial Transplant Assoc; 1983; 20():469-72. PubMed ID: 6657671 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of effects of novel urease inhibitor, N-(pivaloyl)glycinohydroxamic acid on the formation of an infection bladder stone using a newly designed urolithiasis model in rats. Satoh M; Munakata K; Takeuchi H; Yoshida O; Takebe S; Kobashi K Chem Pharm Bull (Tokyo); 1991 Apr; 39(4):894-6. PubMed ID: 1893494 [TBL] [Abstract][Full Text] [Related]
6. Therapy for urolithiasis with hydroxamic acids. IV. Prevention of infected urinary stone formation with N-(pivaloyl)glycinohydroxamic acid. Satoh M; Munakata K; Kitoh K; Seto N; Kanazawa T; Takeuchi H; Yoshida O J Pharmacobiodyn; 1981 Jul; 4(7):469-74. PubMed ID: 7028944 [TBL] [Abstract][Full Text] [Related]
7. Calculosis in paraplegia. Burr RG Int Rehabil Med; 1981; 3(3):162-7. PubMed ID: 6800972 [No Abstract] [Full Text] [Related]
9. A randomized trial of acetohydroxamic acid for the treatment and prevention of infection-induced urinary stones in spinal cord injury patients. Griffith DP; Khonsari F; Skurnick JH; James KE J Urol; 1988 Aug; 140(2):318-24. PubMed ID: 3294442 [TBL] [Abstract][Full Text] [Related]
10. [Prevention of infected urinary stones by urease inhibitor. IV. Treatment of infection stones in rats by a new hydroxamic acid and cefalexin]. Takeuchi H; Tomoyoshi T; Okada Y; Yoshida O; Kobashi K Hinyokika Kiyo; 1983 Mar; 29(3):297-302. PubMed ID: 6375315 [TBL] [Abstract][Full Text] [Related]
12. [Acetylhydroxamic acid in the treatment of nephrolithiasis, caused by infection with urease forming microorganisms]. Lorenz J; Lorenz K; Dabrowska B; Kowal R Z Urol Nephrol; 1989 Dec; 82(12):685-9. PubMed ID: 2698024 [TBL] [Abstract][Full Text] [Related]
13. Clinical experience with low dosage of propionohydroxamic acid (PHA) in infected renal stones. Martelli A; Buli P; Spatafora S Urology; 1986 Nov; 28(5):373-5. PubMed ID: 3787895 [TBL] [Abstract][Full Text] [Related]
14. Prevention of infected urinary stones in rats by urease inhibitor: a new hydroxamic acid derivative. Takeuchi H; Kobashi K; Yoshida O Invest Urol; 1980 Sep; 18(2):102-5. PubMed ID: 6997228 [TBL] [Abstract][Full Text] [Related]
15. Acetohydroxamic acid: clinical studies of a urease inhibitor in patients with staghorn renal calculi. Griffith DP; Gibson JR; Clinton CW; Musher DM J Urol; 1978 Jan; 119(1):9-15. PubMed ID: 23442 [TBL] [Abstract][Full Text] [Related]
16. Adjunctive chemotherapy of infection-induced staghorn calculi. Griffith DP; Moskowitz PA; Carlton CE Trans Am Assoc Genitourin Surg; 1978; 70():25-9. PubMed ID: 380109 [TBL] [Abstract][Full Text] [Related]
17. Stone formation in paraplegia. Smith PH; Cook JB; Robertson WG Paraplegia; 1969 Aug; 7(2):77-85. PubMed ID: 5806665 [No Abstract] [Full Text] [Related]
18. Benurestat, a urease inhibitor for the therapy of infected ureolysis. Andersen JA Invest Urol; 1975 Mar; 12(5):381-6. PubMed ID: 1089613 [TBL] [Abstract][Full Text] [Related]